中国实用神经疾病杂志
中國實用神經疾病雜誌
중국실용신경질병잡지
CHINESE JOURNAL OF PRACTICAL NERVOUS DISEASES
2015年
13期
20-22
,共3页
熊浩锋%熊海兵%程强%楚江云
熊浩鋒%熊海兵%程彊%楚江雲
웅호봉%웅해병%정강%초강운
颅内动脉瘤%栓塞术%支架%低分子肝素%颅内出血%脑血栓形成
顱內動脈瘤%栓塞術%支架%低分子肝素%顱內齣血%腦血栓形成
로내동맥류%전새술%지가%저분자간소%로내출혈%뇌혈전형성
Intracranial aneurysms%Embolization%Stent%Low molecular weight heparin%Intracranial hemorrhage%Cerebral infarction
目的:探讨支架辅助动脉瘤栓塞术前早期应用低分子肝素的有效性和安全性。方法将90例行支架辅助动脉瘤栓塞术的患者随机分为低分子肝素(LMWH)组42例和对照组48例。LMWH组术前使用阿司匹林300 mg+氯吡格雷75 mg+低分子肝素2500 IU抗凝,对照组术前只使用阿司匹林300 mg+氯吡格雷75 mg抗凝。比较分析2组颅内出血及支架内血栓形成的发病率。结果 LMWH组与对照组围手术期发生颅内出血差异无统计学意义(P>0.05),LMWH组较对照组更少发生支架内血栓形成差异有统计学意义( P<0.05)。结论术前给予低分子肝素抗凝治疗不会增加颅内出血的风险,可减少支架内血栓形成发病率。
目的:探討支架輔助動脈瘤栓塞術前早期應用低分子肝素的有效性和安全性。方法將90例行支架輔助動脈瘤栓塞術的患者隨機分為低分子肝素(LMWH)組42例和對照組48例。LMWH組術前使用阿司匹林300 mg+氯吡格雷75 mg+低分子肝素2500 IU抗凝,對照組術前隻使用阿司匹林300 mg+氯吡格雷75 mg抗凝。比較分析2組顱內齣血及支架內血栓形成的髮病率。結果 LMWH組與對照組圍手術期髮生顱內齣血差異無統計學意義(P>0.05),LMWH組較對照組更少髮生支架內血栓形成差異有統計學意義( P<0.05)。結論術前給予低分子肝素抗凝治療不會增加顱內齣血的風險,可減少支架內血栓形成髮病率。
목적:탐토지가보조동맥류전새술전조기응용저분자간소적유효성화안전성。방법장90례행지가보조동맥류전새술적환자수궤분위저분자간소(LMWH)조42례화대조조48례。LMWH조술전사용아사필림300 mg+록필격뢰75 mg+저분자간소2500 IU항응,대조조술전지사용아사필림300 mg+록필격뢰75 mg항응。비교분석2조로내출혈급지가내혈전형성적발병솔。결과 LMWH조여대조조위수술기발생로내출혈차이무통계학의의(P>0.05),LMWH조교대조조경소발생지가내혈전형성차이유통계학의의( P<0.05)。결론술전급여저분자간소항응치료불회증가로내출혈적풍험,가감소지가내혈전형성발병솔。
Objective To evaluate the safety and efficacy of the application of low molecular weight heparin(LMWH) in intracranial aneurysms patients treated by preoperative stent‐assisted embolization.Methods 45 intracranial aneurysms patients with preoperative stent‐assisted embolization were selected and randomly divided into LMWH group and the control group. The LMWH group patients were treated with aspirin(300 mg)+ticlopidine(75 mg)+LMWH(2500 IU);the control group patients received aspirin(300 mg)+ ticlopidine(75 mg). We compared and analyzed the incidence of cerebral infarction and intracranial hemorrhage of the two groups. Results Compared with control group in perioperative period ,the incidence of intracranial hemorrhage in the LMWH group showed no significant difference(P>0.05) ,while the incidence of stent thrombosis in LM‐WH group was lower than that in control group(P<0.05) .Conclusion Anticoagulation therapy with low molecular weight heparin before operation does not increase the risk of intracranial hemorrhage and can reduce the risk of cerebral infarction .